ROS also interact with unsaturated fatty acids in phospholipids, and aldehydes such as 4-hydroxynonenal, 4-hydroxyhexanal, acrolein, and MDA are the most reactive compounds (87)
Current clinical consensus is that combination therapy remains investigational and should only be pursued under physician supervision with baseline and monthly labs, especially for metabolic markers and cardiovascular safety
Effects of the product: supports the brightening of discolourations, evens out the skin tone, improves hydration, supports regenerative processes, has anti-aging effect
We retrospectively examined adherence to secondary prevention medication 1 year post stroke
In this study, 56 cases and 39 control patients were included
: BPC-157 , (, )